Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Somavert (Pegvisomant).
Diabetes: Somavert (Pegvisomant) may lower blood glucose levels. If you have diabetes, discuss with your doctor how Somavert (Pegvisomant) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Somavert (Pegvisomant), and whether any special monitoring is needed.
Latex: The stopper of the vials of Somavert (Pegvisomant) may contain latex.
Liver function: Somavert (Pegvisomant) may cause an increase in liver function test values and may cause liver problems. Your doctor will monitor your liver function with regular blood tests while you are taking Somavert (Pegvisomant). Using Somavert (Pegvisomant) in combination with Octreotide (another medication to treat acromegaly) may increase the risk of liver damage due to the medication.
If you experience yellowing of the skin or eyes, abdominal pain, nausea, vomiting, loss of appetite, fatigue, or easy bruising while taking Somavert (Pegvisomant), contact your doctor immediately.
If you have liver disease or decreased liver function, discuss with your doctor how Somavert (Pegvisomant) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Somavert (Pegvisomant), and whether any special monitoring is needed.
Tumour growth: Somavert (Pegvisomant) may cause tumours that secrete growth hormones to grow. If you have such a tumour, you doctor will monitor you closely while you are using Somavert (Pegvisomant).
Pregnancy: Somavert (Pegvisomant) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Somavert (Pegvisomant), contact your doctor immediately.
Breast-feeding: It is not known if Somavert (Pegvisomant) passes into breast milk. If you are a breast-feeding mother and are taking Somavert (Pegvisomant), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Somavert (Pegvisomant) have not been established for children.
Seniors: There is limited information about the safety and effectiveness of using Somavert (Pegvisomant) for seniors.